posted on 2021-06-25, 14:16authored byWei Ping Khor, Omotayo Olaoye, Nikki D’Arcy, Eva M Krockow, Rasha Abdelsalam Elshenawy, Victoria Rutter, Diane Ashiru-Oredope
The coronavirus disease (COVID-19) pandemic, which has significant impact on global health care delivery, occurs amid the ongoing global health crisis of antimicrobial resistance. Early data demonstrated that bacterial and fungal co-infection with COVID-19 remain low and indiscriminate use of antimicrobials during the pandemic may worsen antimicrobial resistance It is, therefore, essential to maintain the ongoing effort of antimicrobial stewardship activities in all sectors globally.
Funding
This project was funded as part of the CwPAMS supported by the Tropical Health and Education Trust (THET) and the CPA using official development assistance (ODA) funding, through the Department of Health and Social Care’s Fleming Fund. The Fleming Fund is a £265 million UK aid investment to tackle antimicrobial resistance by supporting low- and middle-income countries to generate, use and share data on AMR. The programme is managed by the UK Department of Health and Social Care. T
History
Citation
Antibiotics 2020, 9(12), 904
Author affiliation
Department of Neuroscience, Psychology and Behaviour